Plus Therapeutics Announces Private Placement Financing of up to $18 Million (GlobeNewswire) - May 6, 2024 - "Plus Therapeutics, Inc...announced that it has entered into a securities purchase agreement with new institutional investors and Company insiders to raise up to approximately $18 million in gross proceeds, including initial upfront funding of approximately $6.5 million, and up to an additional approximately $11.5 million upon cash exercise of accompanying warrants at the election of the investors....The Company intends to use the upfront net proceeds from the private placement for general corporate purposes and to fund the Re-SPECT LM clinical development program."
Financing • CNS Tumor • Oncology • Solid Tumor
|